miR-143-3p Promotes TSCM Differentiation and Inhibits Progressive T Cell Differentiation via Inhibiting ABL2 and PAG1
miR-143-3p promotes T<sub>SCM</sub> differentiation and inhibits progressive differentiation by targeting ABL2/PAG1, suggesting new ACT optimization strategies.
Authors
- Changli Tao (ORCID: https://orcid.org/0000-0003-0398-9646)
- Hui Zhong (ORCID: https://orcid.org/0000-0001-8536-6674)
- Wen-Kai Shi
- Hongqiong Wang (ORCID: https://orcid.org/0000-0001-9419-1554)
- Wenfeng Zhang (ORCID: https://orcid.org/0000-0002-6113-0285)
- Fenglin Wu (ORCID: https://orcid.org/0000-0001-8287-4585)
- Han Shen (ORCID: https://orcid.org/0000-0003-0366-4403)
- Jinquan Wang (ORCID: https://orcid.org/0000-0003-3289-9260)
- Jieming Hu (ORCID: https://orcid.org/0009-0007-8342-8983)
- Hongwei Shao (ORCID: https://orcid.org/0000-0001-5998-652X)
- Huaben Bo
Institutions
- Guangdong Pharmaceutical University (CN)
Publication Details
- Journal
- Genes
- Published
- 2025-04-19
- DOI
- https://doi.org/10.3390/genes16040466
- Citations
- 2
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province